QHP Capital, L.P. (“QHP”) announced the closing of a $1.1 Billion single-asset continuation vehicle for Azurity Pharmaceuticals, Inc. (“Azurity”). The transaction provides liquidity to existing limited partners while enabling QHP to maintain control and continue executing on Azurity’s long-term value creation plan. The transaction was led by HarbourVest Partners, LLC (“HarbourVest”), with Pantheon Ventures, L.P. participating as a significant investor. Audax Strategic Capital (“ASC”) also participated through a separate structured growth investment. ASC also invested into the continuation vehicle as a syndicate investor.
Read the full article: QHP Announces $1.1B Continuation Vehicle for Azurity Pharmaceuticals //
Source: https://www.businesswire.com/news/home/20260318178840/en/QHP-Announces-%241.1-Billion-Continuation-Vehicle-for-Azurity-Pharmaceuticals